Deutsche Bank Downgrades Amedisys (AMED) to Hold

Deutsche Bank analyst Justin Bowers downgraded Amedisys (NASDAQ: AMED) from Buy to Hold with a price target of $101.00.

The analyst comments "We are updating our model to incorporate the pending acquisition by Optum (UnitedHealth). We believe Amedisys' recent divestiture of certain home health assets signals progress towards the Optum for AMED deal closure this year and downgrade the stock to Hold. Our $101 TP reflects the deal price."

For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.

Shares of Amedisys closed at $98.25 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Air T reports revenue jump but widens operating loss in Q1 fiscal 2027
• Mosaic sets pricing for tender offers on up to $1.4B in debt